Mary C. Breinig

807 total citations
18 papers, 615 citations indexed

About

Mary C. Breinig is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Mary C. Breinig has authored 18 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Mary C. Breinig's work include Herpesvirus Infections and Treatments (6 papers), Viral-associated cancers and disorders (4 papers) and Immune Response and Inflammation (4 papers). Mary C. Breinig is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Viral-associated cancers and disorders (4 papers) and Immune Response and Inflammation (4 papers). Mary C. Breinig collaborates with scholars based in United States and United Kingdom. Mary C. Breinig's co-authors include Monto Ho, John A. Armstrong, M. Ho, Rafael Máñez, John Wilson, Stephen Dummer, Peter Linden, Shimon Kusne, Robert W. Atchison and J L McKnight and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

Mary C. Breinig

18 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary C. Breinig United States 11 329 296 143 129 80 18 615
Patricia Baré Argentina 16 228 0.7× 100 0.3× 198 1.4× 173 1.3× 52 0.7× 46 665
N H Collins United States 10 221 0.7× 152 0.5× 107 0.7× 443 3.4× 25 0.3× 14 704
Brian A.B. Martin United Kingdom 8 362 1.1× 480 1.6× 220 1.5× 77 0.6× 274 3.4× 15 767
Riccarda Capaul Switzerland 14 317 1.0× 378 1.3× 118 0.8× 320 2.5× 173 2.2× 18 712
Bryce Barr Canada 7 433 1.3× 241 0.8× 33 0.2× 68 0.5× 33 0.4× 14 565
J.M. Huraux France 11 270 0.8× 238 0.8× 229 1.6× 79 0.6× 96 1.2× 33 631
Nicole Castelblanco United States 6 268 0.8× 195 0.7× 61 0.4× 712 5.5× 25 0.3× 6 897
Paula Amat Spain 16 351 1.1× 126 0.4× 115 0.8× 127 1.0× 17 0.2× 46 625
Sharon Nahill United States 10 218 0.7× 100 0.3× 74 0.5× 810 6.3× 21 0.3× 13 1.1k
R C Burton United States 13 227 0.7× 150 0.5× 40 0.3× 542 4.2× 20 0.3× 27 821

Countries citing papers authored by Mary C. Breinig

Since Specialization
Citations

This map shows the geographic impact of Mary C. Breinig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Breinig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Breinig more than expected).

Fields of papers citing papers by Mary C. Breinig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary C. Breinig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Breinig. The network helps show where Mary C. Breinig may publish in the future.

Co-authorship network of co-authors of Mary C. Breinig

This figure shows the co-authorship network connecting the top 25 collaborators of Mary C. Breinig. A scholar is included among the top collaborators of Mary C. Breinig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary C. Breinig. Mary C. Breinig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Máñez, Rafael, Mary C. Breinig, Peter Linden, et al.. (1997). Posttransplant Lymphoproliferative Disease in Primary Epstein‐Barr Virus Infection after Liver Transplantation: The Role of Cytomegalovirus Disease. The Journal of Infectious Diseases. 176(6). 1462–1467. 190 indexed citations
2.
McKnight, J L, et al.. (1994). EBV Gene Expression, EBNA Antibody Responses and EBV+Peripheral Blood Lymphocytes in Post-Transplant Lymphoproliferative Disease. Leukemia & lymphoma. 15(1-2). 9–16. 19 indexed citations
3.
Cen, Han, Mary C. Breinig, Robert W. Atchison, M. Ho, & J L McKnight. (1991). Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. Journal of Virology. 65(2). 976–980. 89 indexed citations
4.
Rahman, Mohammed Atiqur, Lawrence Kingsley, Robert W. Atchison, et al.. (1991). Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. Journal of Clinical Microbiology. 29(6). 1215–1220. 32 indexed citations
5.
Harger, James H., George J. Pazin, & Mary C. Breinig. (1986). Current understanding of the natural history of genital herpes simplex infections.. PubMed. 31(5 Suppl). 365–73. 9 indexed citations
6.
Harger, James H., George J. Pazin, John A. Armstrong, Mary C. Breinig, & Monto Ho. (1983). Characteristics and management of pregnancy in women with genital herpes simplex virus infection. American Journal of Obstetrics and Gynecology. 145(7). 784–791. 38 indexed citations
7.
Pazin, George J., Monto Ho, Harry W. Haverkos, et al.. (1982). Effects of Interferon-Alpha on Human Warts. Journal of Interferon Research. 2(2). 235–243. 29 indexed citations
8.
Breinig, Mary C., Monto Ho, Linda T. White, et al.. (1982). Effect of Prolonged Administration of Interferon-Alpha on Pharmacokinetics, Fever, Lymphocyte Proliferative Response, and NK Cell Activity. Journal of Interferon Research. 2(2). 195–207. 14 indexed citations
9.
Ho, Monto & Mary C. Breinig. (1981). [16] Preparation and characterization of rabbit interferon. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 131–138. 3 indexed citations
10.
Ho, M., Linda T. White, Harry W. Haverkos, et al.. (1981). Depression of Natural Killer Cell Activity by Interferon. The Journal of Infectious Diseases. 144(6). 605–605. 10 indexed citations
11.
Morahan, Page S., et al.. (1979). Effect of Pyran on Latency After Herpes Simplex Virus Infections. Antimicrobial Agents and Chemotherapy. 15(4). 547–553. 8 indexed citations
12.
Breinig, Mary C., et al.. (1978). Resistance to vaginal or systemic infection with herpes simplex virus type 2. Archives of Virology. 57(1). 25–34. 16 indexed citations
13.
Morahan, Page S., et al.. (1978). Immune responses to vaginal or systemic infection of mice with herpes simplex virus type 2.. PubMed. 759–63. 1 indexed citations
14.
Morahan, Page S., et al.. (1977). Immune Responses to Vaginal or Systemic Infection of BALB/c Mice with Herpes Simplex Virus Type 2. The Journal of Immunology. 119(6). 2030–2036. 42 indexed citations
15.
Breinig, Mary C., et al.. (1976). Cellular Basis of Interferon Formation and Hyporeactivity after Exposure to Bacterial Lipopolysaccharide. The Journal of Infectious Diseases. 133(Supplement 2). A30–A36. 9 indexed citations
16.
Breinig, Mary C., John A. Armstrong, & M. Ho. (1975). Rapid Onset of Hyporesponsiveness to Interferon Induction on Re-exposure to Polyribonucleotide. Journal of General Virology. 26(2). 149–158. 10 indexed citations
17.
Ho, Monto, John A. Armstrong, & Mary C. Breinig. (1975). INTERFERON. Annual Review of Microbiology. 29(1). 131–161. 90 indexed citations
18.
Breinig, Mary C., et al.. (1973). Virus Resistance in Rabbit Kidney Cell Cultures Contaminated by a Protozoan Resembling Encephalitozoon cuniculi. Experimental Biology and Medicine. 142(4). 1205–1208. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026